...
首页> 外文期刊>Bone >Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
【24h】

Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.

机译:甲状旁腺激素1-84治疗的绝经后骨质疏松妇女的骨和皮质骨结构及turnover骨周转率。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Treatment with parathyroid hormone [PTH(1-84)] increases lumbar spine bone mineral density and decreases vertebral fractures, but its effects on bone microarchitecture are unknown. We obtained iliac crest biopsies from postmenopausal osteoporotic women given placebo (n=8) or 100 microg PTH(1-84) for 18 (n=8) or 24 (n=7) months to assess cancellous and cortical bone formation and structure. At 18 months, cancellous bone volume (BV/TV) measured by microcomputed tomography and histomorphometry was 45-48% higher in subjects treated with PTH(1-84) versus placebo, a result of higher trabecular number (Tb.N) and thickness. The higher Tb.N appeared to result from intratrabecular tunneling. Connectivity density was higher and structure model index was lower, indicating a better connected and more plate-like trabecular architecture. Cancellous bone formation rate (BFR) was 2-fold higher in PTH(1-84)-treated subjects, primarily because of greater mineralizing surface. Osteoblast and osteoid surfaces were a nonsignificant 58% and 35%, respectively, higher with PTH(1-84) treatment. Osteoclast and eroded surface were unaffected by PTH(1-84). There were no effects of PTH(1-84) treatment on cortical thickness, or endocortical or periosteal BFR, but cortical porosity tended to be higher. Although cancellous BFR was lower at 24 than at 18 months, measures of cancellous and cortical bone structure were similar at both timepoints. The bone produced by PTH(1-84) had normal lamellar structure and mineralization with no abnormal histology. In conclusion, when compared with placebo, treatment of osteoporotic women with PTH(1-84) was associated with higher BV/TV and trabecular connectivity, with a more plate-like architecture, all consistent with the lower vertebral fracture incidence.
机译:甲状旁腺激素[PTH(1-84)]的治疗可增加腰椎骨矿物质密度并减少椎骨骨折,但对骨微结构的影响尚不清楚。我们从绝经后骨质疏松症妇女中服用安慰剂(n = 8)或100微克PTH(1-84)进行了18(n = 8)或24(n = 7)个月的骨活检,以评估松质和皮质骨的形成和结构。在18个月时,用PTH(1-84)治疗的受试者通过微计算机断层扫描和组织形态计量学测得的松质骨体积(BV / TV)比安慰剂高45-48%,这是由于小梁数目(Tb.N)和厚度增加。较高的Tb.N似乎是由于小梁内穿隧造成的。连接密度较高,结构模型指数较低,表明连接性更好,板状小梁结构更多。在PTH(1-84)治疗的受试者中,松质骨形成率(BFR)高2倍,这主要是因为更大的矿化表面。 PTH(1-84)处理的成骨细胞和类骨质表面分别无统计学意义,分别为58%和35%。破骨细胞和侵蚀的表面不受PTH(1-84)的影响。 PTH(1-84)处理对皮质厚度,皮质内膜或骨膜BFR没有影响,但皮质孔隙率往往更高。尽管24个月的松质BFR低于18个月,但两个时间点的松质和皮质骨结构指标相似。 PTH(1-84)产生的骨具有正常的层状结构和矿化,没有异常的组织学。总之,与安慰剂相比,PTH(1-84)治疗骨质疏松妇女的BV / TV和小梁连接性更高,板状结构更强,所有这些都与较低的椎骨骨折发生率相符。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号